OTLK
Haddadin Yezan Munther, OTLK's Director, spent $24.1K of their own money on 29,000 shares at $1, growing their stake 78%.
+$24.1K
29,000 sh @ $1
OTLK
Outlook Therapeutics, Inc.
SEC CIK 1649989
$1.17
+191.3% · 90 days
90-day buys
$5.27M
6 open-market
90-day sells
$0
0 open-market
Net insider flow
+$5.27M
Net buying
Filings shown
7
Most recent
Advertisement
At a glance
Over the last 90 days, insiders at OTLK have bought a net $5.27M of stock (6 open-market buys vs 0 sells).
Largest recent trade: Sukhtian Ghiath M., OTLK's 10% owner, spent $5M of their own money on 8.54M shares at $1, growing their stake 63%.
Insider transaction history
Form 4 filings for OTLK, newest firstOTLK
Sukhtian Ghiath M., OTLK's 10% owner, spent $5M of their own money on 8.54M shares at $1, growing their stake 63%.
+$5M
8.54M sh @ $1
OTLK
Sukhtian Faisal Ghiath, OTLK's Director, spent $50K of their own money on 122,174 shares at $0, growing their stake 3593%.
+$50K
122,174 sh @ $0
OTLK
Haddadin Yezan Munther, OTLK's Director, spent $15K of their own money on 34,000 shares at $0, growing their stake 1074%.
+$15K
34,000 sh @ $0
OTLK
Thurman Randy H, OTLK's Director, spent $2.1K of their own money on 5,000 shares at $0, growing their stake 843%.
+$2.1K
5,000 sh @ $0
Advertisement
OTLK
Hilzinger Kurt J, OTLK's Director, spent $176.5K of their own money on 400,000 shares at $0, growing their stake 1691%.
+$176.5K
400,000 sh @ $0
OTLK
+$6M
4.29M sh @ $1
Advertisement
About OTLK insider activity
This page tracks every recent Form 4 filed for Outlook Therapeutics, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.
The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.
Frequently asked questions
How often is OTLK insider data updated?
Continuously. We read from SEC EDGAR, so new Form 4 filings for Outlook Therapeutics, Inc. usually appear here within minutes of being accepted by the SEC.
What does "net insider flow" mean?
It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.
Why do some rows show grants or option exercises instead of buys?
Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.
Is this investment advice?
No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.